@prefix ns1: <http://schema.org/> .

{
    <http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=397941> a ns1:MedicalCondition ;
        ns1:alternateName "Carbohydrate deficient glycoprotein syndrome type II due to MAN1B1 deficiency",
            "Congenital disorder of glycosylation type 2 due to MAN1B1 deficiency",
            "Congenital disorder of glycosylation type II due to MAN1B1 deficiency",
            "Intellectual disability-truncal obesity syndrome" ;
        ns1:code [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:397941" ;
                ns1:codingSystem "ORPHAcode" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:397941" ;
                ns1:codingSystem "ORPHAcode" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "12417" ;
                ns1:codingSystem "GARD" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "12417" ;
                ns1:codingSystem "GARD" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "E77.8" ;
                ns1:codingSystem "ICD-10" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "E77.8" ;
                ns1:codingSystem "ICD-10" ] ;
        ns1:description "MAN1B1-CDG is a form of congenital disorders of N-linked glycosylation characterized by intellectual disability, delayed motor development, hypotonia and truncal obesity. Additional features include slight facial dysmorphism (hypertelorism, downslanting palpebral fissures, large, low-set ears, hypoplastic nasolabial fold, thin upper lip), hypermobility of the joints and skin laxity. The disease is caused by mutations in the gene <i>MAN1B1</i> (9q34.3)." ;
        ns1:epidemiology "Prevalence : <1 / 1 000 000" ;
        ns1:identifier "397941" ;
        ns1:name [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "MAN1B1-CDG" ],
            [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "MAN1B1-CDG" ] .
}

